169 related articles for article (PubMed ID: 24072383)
1. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection.
Wang HJ; Pui MH; Guo Y; Yang D; Pan BT; Zhou XH
Abdom Imaging; 2014 Feb; 39(1):135-41. PubMed ID: 24072383
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
[TBL] [Abstract][Full Text] [Related]
4. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer.
Yoshida S; Koga F; Kawakami S; Ishii C; Tanaka H; Numao N; Sakai Y; Saito K; Masuda H; Fujii Y; Kihara K
Urology; 2010 Feb; 75(2):387-91. PubMed ID: 19914691
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging.
Takeuchi M; Sasaki S; Naiki T; Kawai N; Kohri K; Hara M; Shibamoto Y
J Magn Reson Imaging; 2013 Dec; 38(6):1299-309. PubMed ID: 24265260
[TBL] [Abstract][Full Text] [Related]
6. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
7. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
[TBL] [Abstract][Full Text] [Related]
9. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
10. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
[TBL] [Abstract][Full Text] [Related]
11. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
Kim CK; Park BK; Lee HM; Kim SS; Kim E
AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
13. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
Rosenkrantz AB; Haghighi M; Horn J; Naik M; Hardie AD; Somberg MB; Melamed J; Xiao GQ; Huang WC; Taouli B
AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364
[TBL] [Abstract][Full Text] [Related]
14. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
Zhao SM; Yang TJ; Xu CM; Guo XF; Ma YK; Chen XJ; Li X; He CH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):701-704. PubMed ID: 32773805
[TBL] [Abstract][Full Text] [Related]
15. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
[TBL] [Abstract][Full Text] [Related]
16. Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer.
Wollin DA; Deng FM; Huang WC; Babb JS; Rosenkrantz AB
Can J Urol; 2014 Oct; 21(5):7454-9. PubMed ID: 25347370
[TBL] [Abstract][Full Text] [Related]
17. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
[TBL] [Abstract][Full Text] [Related]
18. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor.
Kitajima K; Tanaka U; Ueno Y; Maeda T; Suenaga Y; Takahashi S; Deguchi M; Miyahara Y; Ebina Y; Yamada H; Tsurusaki M; Tamaki Y; Sugimura K
PLoS One; 2015; 10(1):e0117411. PubMed ID: 25629156
[TBL] [Abstract][Full Text] [Related]
19. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
Nakamura Y; Yoshida S; Tanaka H; Inoue M; Ito M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Fujii Y; Kihara K
Urol Int; 2017; 98(3):298-303. PubMed ID: 28245479
[TBL] [Abstract][Full Text] [Related]
20. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
